Dallah Healthcare Co. (4004) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Dallah Healthcare Co. reported revenue of SAR 4.07B, net profit of SAR 541M, and earnings per share of SAR 5.32. Total assets stood at SAR 9.14B with total equity of SAR 4.08B and total liabilities of SAR 5.02B.

Operating cash flow for 2025 was SAR 555M, representing a cash conversion ratio of 1.03 relative to net profit. Free cash flow was SAR -232M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.03 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.03.

Revenue growth from 2024 to 2025: +26.9%. Net profit growth over the same period: +11.4%. 3-year revenue CAGR: 36.7%. 3-year net profit CAGR: 25.4%.

Key financial ratios for 2025: Return on Equity 13.2%, Return on Assets 5.9%, Net Margin 13.3%, Debt to Equity 1.23.

In 2024, Dallah Healthcare Co. reported revenue of SAR 3.21B and net profit of SAR 485M, compared to SAR 4.07B and SAR 541M respectively in 2025.